GSA Capital Partners LLP decreased its position in China Cord Blood Corp. (NYSE:CO) by 44.5% during the second quarter, Holdings Channel reports. The fund owned 20,577 shares of the company’s stock after selling 16,480 shares during the period. GSA Capital Partners LLP’s holdings in China Cord Blood Corp. were worth $118,000 at the end of the most recent reporting period.
China Cord Blood Corp. (NYSE:CO) traded up 0.38% on Wednesday, hitting $5.23. The stock had a trading volume of 618 shares. The stock has a 50-day moving average of $5.25 and a 200-day moving average of $5.72. The company has a market cap of $381.81 million, a PE ratio of 27.38 and a beta of 0.45. China Cord Blood Corp. has a one year low of $4.93 and a one year high of $6.53.
China Cord Blood Corp. (NYSE:CO) last issued its quarterly earnings results on Monday, August 22nd. The company reported $0.03 earnings per share for the quarter, meeting the Zacks’ consensus estimate of $0.03. China Cord Blood Corp. had a return on equity of 5.85% and a net margin of 13.90%. The business earned $26 million during the quarter, compared to the consensus estimate of $26.23 million. Equities analysts expect that China Cord Blood Corp. will post $0.15 earnings per share for the current fiscal year.
CO has been the topic of a number of research reports. Zacks Investment Research lowered shares of China Cord Blood Corp. from a “hold” rating to a “sell” rating in a research report on Monday, August 29th. TheStreet lowered shares of China Cord Blood Corp. from a “buy” rating to a “hold” rating in a research report on Thursday, August 4th. One analyst has rated the stock with a sell rating, four have assigned a hold rating and one has given a buy rating to the company. China Cord Blood Corp. presently has an average rating of “Hold” and a consensus price target of $6.75.
About China Cord Blood Corp.
China Cord Blood Corporation is a provider of cord blood banking services in China. The Company and its subsidiaries are principally engaged in the provision of umbilical cord blood storage and ancillary services in the People’s Republic of China. It provides cord blood testing, processing and storage services under the direction of subscribers for a cord blood processing fee and a storage fee.
Want to see what other hedge funds are holding CO? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for China Cord Blood Corp. (NYSE:CO).
Receive News & Ratings for China Cord Blood Corp. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for China Cord Blood Corp. and related companies with MarketBeat.com's FREE daily email newsletter.